The Her2 protein is a prevalent clinical marker for malignant tumors and is often accompanied by the upregulation of matrix metalloproteinase (mmp)-2 and mmp-9, thereby promoting tumor proliferation and metastasis (Fig. 1A). Here, MMP9 is linked to neoplasm.